This federal contract award is for the delivery of 4,565,440 units of pyridostigmine bromide 30 mg tablets to the Defense Logistics Agency (DLA). The $7,824.48 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 13, 2024 with an ultimate completion date of August 14, 2024. The contract does not have a set-aside designation. As a large Indefinite Delivery Contract (IDC) holder with the DLA Troop Support Medical valued up to...
The federal contract award described is for the procurement of 4566342092 Pyridostigmine BR 30 mg Tablets by the Defense Logistics Agency (DLA), a defense agency. The $5,845.74 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 5, 2024, with a completion date of November 6, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA...
This federal contract award, valued at $3,527.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 5, 2024. The award supports the procurement of Pyridostigmine BR 30 MG Tablet medical supplies, which are likely intended for military healthcare programs. Amerisourcebergen holds a...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pyridostigmine BR 60 MG Tablet 30S, a medical product, with a ceiling value of $1,415.66 and a completion date of June 4, 2025. The contract is designated as a Firm Fixed Price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is for the delivery of Pyridostigmine Bromide 60 mg tablets, with a ceiling value of $1,105.59 and a period of performance through June 27, 2025. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,140.63, is for the delivery of PYRIDOSTIGMINE BR 30 MG TABLET medical supplies. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,734.33 firm fixed-price delivery order is for the supply of Pyrazinamide tablets, with a period of performance through May 2025. The award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical. This IDC provides a...
This federal contract award is a $36,270.00 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and provides for the delivery of various pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. Amerisourcebergen holds a larger...
This federal contract award, valued at $9,635.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support for military healthcare programs through December 2026. This particular delivery...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $5,475.69 with a completion date of January 9, 2025. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary...